Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance

Hims and Hers Health IncTrade
Vivmark Residential Common Shares of Beneficial InterestTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Hims and Hers Health Inc trades at $28.44 (market cap $6.89B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $45.88B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 6.7× Hims and Hers Health Inc's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.74% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.

HIMSVMRK
Market Cap
$6.89B$45.88B
Volume
5,446,6284,028,975
Sector
HealthReal Estate
52-Week High
$62.76$70.15
52-Week Low
$14.52$57.98
Typical Hold Time
21 Days0 Days
Enterprise Value
$7.60B$54.98B
Dividend Yield
—4.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.

The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.

Vivmark Residential Common Shares of Beneficial Interest

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
86% Buy14% Sell
Avg holding period · 21 Days
VMRK
100% Buy0% Sell
Avg holding period · 0 Days

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About Vivmark Residential Common Shares of Beneficial Interest

Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.

Read more on VMRK →